The University of Arizona
Map Home
Loading...
Adjust height of sidebar
KMap

Grant

A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor Xla Inhibitor, for Stroke Prevention After an Acute Is

Active
$341.3K Funding
4 People
External

Related Topics

People